Skip to main content
. Author manuscript; available in PMC: 2009 May 19.
Published in final edited form as: Radiother Oncol. 2008 Jun 12;89(1):13–18. doi: 10.1016/j.radonc.2008.05.021

Table.

Patient & Treatment Characteristics:

Disease Free Failures
No. patients 47 14
Median Age-yrs 56 61
Gender M/F 38:9 8:6
Stage
          III 4 2
          IVA 37 5
          IVB 6 7
Site
          Oropharynx 37 8
          Larynx 5 2
          Unknown primary 2 2
          Hypopharynx. 1 1
          Nasopharynx 1 1
          Oral cavity 1 0
Concurrent Chemo 94% 100%
          Platinum Based 100% 93%
Median RT Dose-Gy 70 70
          IMRT vs 3-D 33:14 5:9
          RT Duration days 49 47
Mean GTV cm3 (95%CI) 121.5 (99.0-144.0) 229.4 (152.2-306.7) *
Mean SUV (95%CI) 11.6 (7.0-16.2) 12.5 (7.8-17.2) †
Max SUV (95%CI) 14.1(9.2-19.0) 14.9 (9.8-20.1) #
*

Statistically significant difference p=0.003.

†

Not statistically different p=0.13.

#

Not statistically different p=0.25.